Treating Erectile Dysfunction and Central Neurological Diseases with Oral Phosphodiesterase Type 5 Inhibitors. Review of the Literature

Journal of Sexual Medicine

Volumn 9, Issue 4, 2012, Pages 970-985

  Lombardi, Giuseppe ^a   Nelli, Federico ^a   Celso, Maria ^a   Mencarini, Marco ^a   Del Popolo, Giulio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Central neurogenic diseases; Erectile dysfunction; Multiple sclerosis; Parkinson's disease; PDE5 inhibitors; Spinal cord injury

Indexed keywords

PLACEBO; PROSTAGLANDIN E1; SILDENAFIL; TADALAFIL; VARDENAFIL;

ABDOMINAL PAIN; ALZHEIMER DISEASE; AUTONOMIC DYSREFLEXIA; BACKACHE; CONJUNCTIVITIS; DEPRESSION; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPEPSIA; EPILEPSY; ERECTILE DYSFUNCTION; HEAD INJURY; HUMAN; HYPOTENSION; LIFE SATISFACTION; MEDICAL LITERATURE; MEDLINE; MOTOR NEURON DISEASE; MULTIPLE SCLEROSIS; MYALGIA; NAUSEA; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT SATISFACTION; PRIAPISM; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; SHY DRAGER SYNDROME; SPINA BIFIDA; SPINAL CORD INJURY; STROKE; SYSTEMATIC REVIEW; THORAX PAIN; VISUAL IMPAIRMENT; WELLBEING;

EID: 84859269838     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02615.x     Document Type: Review

References (75)

1. Lue TF. Neurogenic erectile dysfunction. Clin Auton Res 2001;11:285-94.
2. Redouté J, Stoléru S, Grégoire MC, Costes N, Cinotti L, Lavenne F, Le Bars D, Forest MG, Pujol JF. Brain processing of visual sexual stimuli in human males. Hum Brain Mapp 2000;11:162-77.
3. Miyagawa Y, Tsujimura A, Fujita K, Matsuoka Y, Takahashi T, Takao T, Takada S, Matsumiya K, Osaki Y, Takasawa M, Oku N, Hatazawa J, Kaneko S, Okuyama A. Differential brain processing of audiovisual sexual stimuli in men: Comparative positron emission tomography study of the initiation and maintenance of penile erection during sexual arousal. Neuroimage 2007;36:830-42.
4. Ferretti A, Caulo M, Del Gratta C, Di Matteo R, Merla A, Montorsi F, Pizzella V, Pompa P, Rigatti P, Rossini PM, Salonia A, Tartaro A, Romani GL. Dynamics of male sexual arousal: Distinct components of brain activation revealed by fMRI. Neuroimage 2005;26:1086-96.
5. Tsujimura A, Miyagawa Y, Fujita K, Matsuoka Y, Takahashi T, Takao T, Matsumiya K, Osaki Y, Takasawa M, Oku N, Hatazawa J, Kaneko S, Okuyama A. Brain processing of audiovisual sexual stimuli inducing penile erection: A positron emission tomography study. J Urol 2006;176:679-83.
6. Sakakibara R, Uchiyama T, Yamanishi T, Kishi M. Genitourinary dysfunction in Parkinson's disease. Mov Disord 2010;25:2-12. Review.
7. Rees PM, Fowler CJ, Maas CP. Sexual dysfunction in men and women with neurological disorders. Lancet 2007;369:512-25.
8. Smaldone M, Sukkarieh T, Reda A, Khan A. Epilepsy and erectile dysfunction: A review. Seizure 2004;13:453-9.
9. Brown RG, Mac Carthy B, Gotham AM, Der GJ, Marsden CD. Depression and disability in Parkinson's disease: A follow-up of 132 cases. Psychol Med 1998;18:49-55.
10. Bener A, Al-Hamaq AO, Kamran S, Al-Ansari A. Prevalence of erectile dysfunction in male stroke patients, and associated co-morbidities and risk factors. Int Urol Nephrol 2008;40:701-8.
11. Bronner G, Royter V, Korczyn AD, Giladi N. Sexual dysfunction in Parkinson's disease. J Sex Marital Ther 2004;30:95-105.
12. Kirchhof K, Apostolidis AN, Mathias CJ, Fowler CJ. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: A retrospective study. Int J Impot Res 2003;15:293-8.
13. Bakke A, Myhr K, Grooning M, Nyland H. Bladder, bowel and sexual dysfunction in patients with multiple sclerosis -a cohort study. Scand J Urol Nephrol Suppl 1996;179:61-6.
14. Stien R. Sexual dysfunction in men with spinal injuries. Tidsskr Nor Laegeforen 2008;128:453-6.
15. Courtois FJ, Charvier KF, Leriche A, Raymond DP. Sexual function in spinal cord injury men. Assessing sexual capability. Paraplegia 1993;31:771-84.
16. Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Morassi P, Iona LG, Cazzato G. Sexual dysfunction in multiple sclerosis: A casecontrol study. Frequency and comparison of groups. Mult Scler 1999;5:418-27.
17. Nikoobakht M, Motamedi M, Orandi A, Meysamie A, Emamzadeh A. Sexual dysfunction in epileptic men. Urol J 2007;4:111-7.
18. Singer C, Weiner WJ, Sanchez-Ramos JR, Ackerman M. Sexual dysfunction in men with Parkinson's disease. J Neurol Rehabil 1989;3:199-204.
19. Beck RO, Betts CD, Fowler CJ. Genitourinary dysfunction in multiple systemic atrophy: Clinical features and treatment in 62 cases. J Urol 1994;151:1336-41.
20. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30.
21. Maytom MC, Derry FA, Dinsmore WW, Glass CA, Smith MD, Orr M, Osterloh IH. A two part pilot study of sildenafil (VIAGRA) in men with erectile dysfunction caused by spinal cord injury. Spinal Cord 1999;37(suppl 2):110-6.
22. Yildiz N, Gokkaya NK, Koseglu F, Gokkaya S, Comert D. Efficacies of papaverine and sildenafil in the treatment of erectile dysfunction in early-stage paraplegic men. Int J Rehabil Res 2011;34:44-52.
23. Manou BK, van Tam PN, Sesay M, Joseph P, Alloh DA, Bombo J, Koakou J, Nandjui BM. Effect of sildenafil on erectile dysfunction in spinal cord injured patients. Ghana Med J 2009;43:132-4.
24. Safarinejad MR, Taghva A, Shekarchi B, Safarinejad S. Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: A double-blind, placebo-controlled, randomized study. Int J Impot Res 2010;22:325-35.
25. Blonder LX, Slevin JT. Emotional dysfunction in Parkinson's disease. Behav Neurol 2011;24:201-17.
26. Derry F, Hutling C, Seftel AD, Sipski ML. Efficacy and safety of Sildenafil citrate (Viagra) in men with erectile dysfunction and spinal cord injury. A review. Urology 2002;60:49-57.
27. Lombardi G, Macchiarella A, Cecconi F, Del Popolo G. Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients. J Sex Med 2009;6:1248-58.
28. Morgentaler A, Barada J, Niederberger C, Donatucci C, Garcia CS, Natanegara F, Ahuja S, Wong DG. Efficacy and safety of tadalafil across ethnic groups and various risk factors in men with erectile dysfunction: Use of a novel non inferiority study design. J Sex Med 2006;3:492-503.
29. Derry FA, Dinsmore WW, Fraser M, Gardner BP, Glass CA, Maytom MC, Smith MD. Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury. Neurology 1998;51:1629-33.
30. Ergin S, Gunduz B, Ugurlu H, Sivrioglu K, Oncel S, Gok H, Erhan B, Levendoglu F, Senocak O. A placebo-controlled, multicenter, randomized, double-blind, flexible-dose, two-way crossover study to evaluate the efficacy and safety of sildenafil in men with traumatic spinal cord injury and erectile dysfunction. J Spinal Cord Med 2008;31:522-31.
31. American Spinal Injury Association. International Standards for Neurological and Functional Classification of Spinal Cord Injury Revised 1996. Chicago: American Spinal Injury Association; 1996.
32. Moemen MN, Fahmy I, Abdelaal M, Kamel I, Mansour M, Arafa MM. Erectile dysfunction in spinal cord-injured men: Different treatment options. Int J Impot Res 2008;20:181-7.
33. Soler JM, Previnaire JG, Denys P, Chartier-Kastler E. Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord-injured men. Spinal Cord 2007;45:169-73.
34. Green BG, Martin S. Clinical assessment of sildenafil in the treatment of neurogenic male sexual dysfunction: After the hype. NeuroRehabilitation 2000;15:101-5.
35. Schmid DM, Schurch B, Hauri D. Sildenafil in the treatment of sexual dysfunction in spinal cord-injured male patients. Eur Urol 2000;38:184-93.
36. Del Popolo G, Li Marzi V, Mondaini N, Lombardi G. Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients. Spinal Cord 2004;42:643-8.
37. Khorrami MH, Javid A, Moshtaghi D, Nourimahdavi K, Mortazavi A, Zia HR. Sildenafil efficacy in erectile dysfunction secondary to spinal cord injury depends on the level of cord injuries. Int J Androl 2010;33:861-4.
38. Gans WH, Zaslau S, Wheeler S, Galea G, Vapnek JM. Efficacy and safety of oral sildenafil in men with erectile dysfunction and spinal cord injury. J Spinal Cord Med 2001;24(1 suppl):35-40.
39. Lombardi G, Macchiarella A, Cecconi F, Del Popolo G. Ten-year follow-up of sildenafil use in spinal cord-injured patients with erectile dysfunction. J Sex Med 2009;6:3449-57.
40. Sánchez Ramos A, Vidal J, Jáuregui ML, Barrera M, Recio C, Giner M, Toribio L, Salvador S, Sanmartín A, de la Fuente M, Santos JF, de Juan FJ, Moraleda S, Méndez JL, Ramírez L, Casado RM. Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries. Spinal Cord 2001;39:637-43.
41. Giuliano F, Hultling C, El Masry WS, Smith MD, Osterloh IH, Orr M, Maytom M. Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Sildenafil Study Group. Ann Neurol 1999;46:15-21.
42. Hultling C, Giuliano F, Quirk F, Peña B, Mishra A, Smith MD. Quality of life in patients with spinal cord injury receiving Viagra (sildenafil citrate) for the treatment of erectile dysfunction. Spinal Cord 2000;38:363-70.
43. Giuliano F, Sanchez-Ramos A, Löchner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. Arch Neurol 2007;64:1584-92.
44. Lombardi G, Macchiarella A, Cecconi F, Del Popolo G. Efficacy and safety of medium and long-term tadalafil use in spinal cord patients with erectile dysfunction. J Sex Med 2009;6:535-43.
45. Kimoto Y, Sakamoto S, Fujikawa K, Tachibana T, Yamamoto N, Otani T. Up-titration of vardenafil dose from 10mg to 20mg improved erectile function in men with spinal cord injury. Int J Urol 2006;13:1428-33.
46. Giuliano F, Rubio-Aurioles E, Kennelly M, Montorsi F, Kim ED, Finkbeiner AE, Pommerville PJ, Colopy MW, Wilkins HJ, Wachs BH; Vardenafil Study Group. Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury. Neurology 2006;66:210-6.
47. Giuliano F, Rubio-Aurioles E, Kennelly M, Montorsi F, Kim ED, Finkbeiner AE, Pommerville PJ, Colopy MW, Wachs BH, Vardenafil Study Group. Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury. Spine 2008;33:709-15.
48. Zesiewicz TA, Helal M, Hauser RA. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease. Mov Disord 2000;15:305-8.
49. Hussain IF, Brady CM, Swinn MJ, Mathias CJ, Fowler CJ. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001;71:371-4.
50. Raffaele R, Vecchio I, Giammusso B, Morgia G, Brunetto MB, Rampello L. Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson's disease. Eur Urol 2002;41:382-6.
51. Hoehn MM, Yahr MD. Parkinsonism: Onset progression and mortality. Neurology 1967;17:427-42.
52. Kurtzke JF. Rating neurological impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
53. Safarinejad MR. Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: A double-blind, placebo controlled, randomized study. J Urol 2009;181:252-8.
54. Fowler CJ, Miller JR, Sharief MK, Hussain IF, Stecher VJ. Sweeney A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76:700-5.
55. Lombardi G, Macchiarella A, Del Popolo G. Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis. J Sex Med 2010;7:2192-200.
56. Palmer JS, Kaplan WE, Firlit CF. Erectile dysfunction in patients with spina bifida is a treatable condition. J Urol 2000;164:958-61.
57. Steers WD. Viagra- after one year. Urology 1999;54:12-7.
58. Rendell MS, Raifer J, Wicker PA. Smith MR for the Sildenafil Diabetes Study Group. Sildenafil for treatment of erectile dysfunction in men with diabetes. JAMA 1999;281:421-6.
59. Kummer A, Cardoso F, Teixeira AL. Loss of libido in Parkinson's disease. J Sex Med 2009;6:1024-31.
60. Hibbard MR, Gordon WA, Flanagan S, Haddad L, Labinsky E. Sexual dysfunction after traumatic brain injury. Brain Injury. NeuroRehabilitation 2000;15:107-20.
61. Sandel ME, Williams KS, Dellapietra L, Derogatis LR. Sexual functioning following traumatic brain injury. Brain Inj 1996;10:719-28.
62. Demirkiran M, Sarica Y, Uguz S, Yerdelen D, Aslan K. Multiple sclerosis patients with and without sexual dysfunction: Are there any differences? Mult Scler 2006;12:209-14.
63. Cardoso FL, Savall AC, Mendes AK. Self-awareness of the male sexual response after spinal cord injury. Int J Rehabil Res 2009;32:294-300.
64. Rickards H. Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke. J Neurol Neurosurg Psychiatry 2005;76:48-52.
65. Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: Systematic review and meta-analysis. J Psychiatr Pract 2009;15:289-305.
66. Giltay EJ, Tishova YA, Mskhalaya GJ, Gooren LJ, Saad F, Kalinchenko SY. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. J Sex Med 2010;7:2572-82.
67. Duncan S, Talbot A, Sheldrick R, Caswell H. Erectile function, sexual desire, and psychological well-being in men with epilepsy. Epilepsy Behav 2009;15:351-7.
68. Talbot JA, Sheldrick R, Caswell H, Duncan S. Sexual function in men with epilepsy: How important is testosterone? Neurology 2008;70:1346-52.
69. Farooq MU, Naravetla B, Moore PW, Majid A, Gupta R, Kassab MY. Role of sildenafil in neurological disorders. Clin Neuropharmacol 2008;31:353-62.
70. Perkovic O, Vitezic D, Rudez J, Vitezic M, Kovacevic M, Mrsic-Pelcic J, Ljubicic D, Jurjevic A. Sildenafil induced choreoathetosis in men with Parkinson's disease. Int J Clin Pharmacol Ther 2010;48:76-8.
71. Carter JE. Anterior ischemic optic neuropathy and stroke with use of PDE-5 inhibitors for erectile dysfunction: Cause or coincidence? J Neurol Sci 2007;262:89-97.
72. Ethans KD, Casey AR, Schryvers OI, MacNeil BJ. The effects of sildenafil on the cardiovascular response in men with spinal cord injury at or above the sixth thoracic level. J Spinal Cord Med 2003;26:222-6.
73. García-Bravo AM, Suárez-Hernández D, Ruiz-Fernández MA, Silva González O, Bárbara-Bataller E, Méndez Suárez JL. Determination of changes in blood pressure during administration of sildenafil (Viagra) in patients with spinal cord injury and erectile dysfunction. Spinal Cord 2006;44:301-8.
74. Gilad R, Lampl Y, Eshel Y, Sadeh M. Tonic-clonic seizures in patients taking sildenafil. BMJ 2002;325:869.
75. Lassmann J, Garibay Gonzalez F, Melchionni JB, Pasquariello PS Jr, Snyder HM 3rd. Sexual function in adult patients with spina bifida and its impact on quality of life. J Urol 2007;178(4 Pt 2):1611-4.